Literature DB >> 27060605

Cocaine-like discriminative stimulus effects of alpha-pyrrolidinovalerophenone, methcathinone and their 3,4-methylenedioxy or 4-methyl analogs in rhesus monkeys.

Douglas A Smith1, S Stevens Negus1,2, Justin L Poklis1, Bruce E Blough3, Matthew L Banks1,2.   

Abstract

Synthetic cathinones are beta-ketone amphetamine analogs that have emerged as a heterogeneous class of abused compounds that function as either monoamine transporter substrates or inhibitors. Pre-clinical drug discrimination procedures are useful for interrogating structure-activity relationships of abuse-related drug effects; however, in vivo structure-activity relationship comparisons between synthetic cathinones with different mechanisms of action are lacking. The aim of the present study was to determine whether the cocaine-like discriminative stimulus effects of the monoamine transporter inhibitor alpha-pyrrolidinovalerophenone (alpha-PVP) and the monoamine transporter substrate methcathinone were differentially sensitive to 3,4-methylenedioxy and 4-methyl substitutions. Male rhesus monkeys (n = 4) were trained to discriminate intramuscular cocaine (0.32 mg/kg) from saline in a two-key food-reinforced discrimination procedure. Potency and timecourse of cocaine-like discriminative stimulus effects were determined for (±)-alpha-PVP, (±)-methcathinone and their 3,4-methylenedioxy or 4-methyl analogs. Alpha-PVP and methcathinone produced dose- and time-dependent cocaine-like effects. A 3,4-methylenedioxy addition to either alpha-PVP or methcathinone (methylone) did not alter the potency or efficacy to produce cocaine-like effects, but did prolong the time course. A 4-methyl addition to alpha-PVP (pyrovalerone) did not alter the potency or efficacy to produce cocaine-like effects, but did prolong the time course. In contrast, addition of a 4-methyl moiety to methcathinone (4MMC; mephedrone) significantly attenuated efficacy to produce cocaine-like effects. Overall, these results suggest different structural requirements for cocaine-like discriminative stimulus effects of monoamine transporter inhibitor and substrate synthetic cathinone analogs. Given that 4MMC is more hydrophobic than MDMC, these results suggest that hydrophobicity may be an important determinant for limiting monoamine transporter substrate abuse-related behavioral effects.
© 2016 Society for the Study of Addiction.

Entities:  

Keywords:  Alpha-PVP; discrimination; non-human primates

Mesh:

Substances:

Year:  2016        PMID: 27060605      PMCID: PMC5639944          DOI: 10.1111/adb.12399

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  45 in total

1.  [Abuse of pyrovalerone by drug addicts].

Authors:  P Deniker; H Lôo; H Cuche; J M Roux
Journal:  Ann Med Psychol (Paris)       Date:  1975-11       Impact factor: 0.380

2.  Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order.

Authors: 
Journal:  Fed Regist       Date:  2011-10-21

3.  The metabolism of pyrovalerone hydrochloride.

Authors:  W Michaelis; J H Russel; O Schindler
Journal:  J Med Chem       Date:  1970-05       Impact factor: 7.446

4.  Emergency department presentations in determining the effectiveness of drug control in the United Kingdom: mephedrone (4-methylmethcathinone) control appears to be effective using this model.

Authors:  David M Wood; Shaun L Greene; Paul I Dargan
Journal:  Emerg Med J       Date:  2011-10-27       Impact factor: 2.740

5.  In vivo potency and efficacy of the novel cathinone α-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats.

Authors:  Shawn M Aarde; Kevin M Creehan; Sophia A Vandewater; Tobin J Dickerson; Michael A Taffe
Journal:  Psychopharmacology (Berl)       Date:  2015-05-01       Impact factor: 4.530

6.  Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats.

Authors:  C T Bauer; M L Banks; B E Blough; S S Negus
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

7.  Presence and composition of cathinone derivatives in drug samples taken from a drug test service in Spain (2010-2012).

Authors:  Fernando Caudevilla-Gálligo; Mireia Ventura; Blanca Iciar Indave Ruiz; Iván Fornís
Journal:  Hum Psychopharmacol       Date:  2013-07       Impact factor: 1.672

8.  Pharmacological characterization of designer cathinones in vitro.

Authors:  L D Simmler; T A Buser; M Donzelli; Y Schramm; L-H Dieu; J Huwyler; S Chaboz; M C Hoener; M E Liechti
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

9.  1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.

Authors:  Peter C Meltzer; David Butler; Jeffrey R Deschamps; Bertha K Madras
Journal:  J Med Chem       Date:  2006-02-23       Impact factor: 7.446

10.  Abuse-related and abuse-limiting effects of methcathinone and the synthetic "bath salts" cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats.

Authors:  J S Bonano; R A Glennon; L J De Felice; M L Banks; S S Negus
Journal:  Psychopharmacology (Berl)       Date:  2013-08-15       Impact factor: 4.530

View more
  11 in total

1.  Locomotor activity and discriminative stimulus effects of a novel series of synthetic cathinone analogs in mice and rats.

Authors:  Michael B Gatch; Sean B Dolan; Michael J Forster
Journal:  Psychopharmacology (Berl)       Date:  2017-02-16       Impact factor: 4.530

2.  Self-administration and behavioral economics of second-generation synthetic cathinones in male rats.

Authors:  S L Huskinson; J E Naylor; E A Townsend; J K Rowlett; B E Blough; K B Freeman
Journal:  Psychopharmacology (Berl)       Date:  2016-11-28       Impact factor: 4.530

Review 3.  Utility of Nonhuman Primates in Substance Use Disorders Research.

Authors:  Matthew L Banks; Paul W Czoty; Sidney S Negus
Journal:  ILAR J       Date:  2017-12-01

4.  Cocaine-like discriminative stimulus effects of amphetamine, cathinone, methamphetamine, and their 3,4-methylenedioxy analogs in male rhesus monkeys.

Authors:  Douglas A Smith; Bruce E Blough; Matthew L Banks
Journal:  Psychopharmacology (Berl)       Date:  2016-10-05       Impact factor: 4.530

5.  Effects of cocaine on the discriminative stimulus and reinforcing effects of mephedrone in male rats.

Authors:  Laura L Erwin; Mark R Nilges; Zachary B Bondy; Peter J Winsauer
Journal:  Psychopharmacology (Berl)       Date:  2018-11-17       Impact factor: 4.530

6.  Self-administration of the synthetic cathinones 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinopentiophenone (α-PVP) in rhesus monkeys.

Authors:  Gregory T Collins; Agnieszka Sulima; Kenner C Rice; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2019-07-26       Impact factor: 4.530

7.  Effects of dopaminergic and serotonergic compounds in rats trained to discriminate a high and a low training dose of the synthetic cathinone mephedrone.

Authors:  Iman Saber; Andrew Milewski; Allen B Reitz; Scott M Rawls; Ellen A Walker
Journal:  Psychopharmacology (Berl)       Date:  2019-04-13       Impact factor: 4.530

8.  Reinforcing effects of abused 'bath salts' constituents 3,4-methylenedioxypyrovalerone and α-pyrrolidinopentiophenone and their enantiomers.

Authors:  Brenda M Gannon; Kenner C Rice; Gregory T Collins
Journal:  Behav Pharmacol       Date:  2017-10       Impact factor: 2.293

9.  The clinical challenges of synthetic cathinones.

Authors:  Fabrizio Schifano; Flavia Napoletano; Davide Arillotta; Caroline Zangani; Liam Gilgar; Amira Guirguis; John Martin Corkery; Alessandro Vento
Journal:  Br J Clin Pharmacol       Date:  2020-02-03       Impact factor: 4.335

10.  Stereoselective neurochemical, behavioral, and cardiovascular effects of α-pyrrolidinovalerophenone enantiomers in male rats.

Authors:  Charles W Schindler; Eric B Thorndike; Hailey M Walters; Donna Walther; Kenner C Rice; Michael H Baumann
Journal:  Addict Biol       Date:  2019-11-13       Impact factor: 4.093

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.